GFER

protein-coding

growth factor, augmenter of liver regeneration

Gene summary

The hepatotrophic factor designated augmenter of liver regeneration (ALR) is thought to be one of the factors responsible for the extraordinary regenerative capacity of mammalian liver. It has also been called hepatic regenerative stimulation substance (HSS). The gene resides on chromosome 16 in the interval containing the locus for polycystic kidney disease (PKD1). The putative gene product is 42% similar to the scERV1 protein of yeast. The yeast scERV1 gene had been found to be essential for oxidative phosphorylation, the maintenance of mitochondrial genomes, and the cell division cycle. The human gene is both the structural and functional homolog of the yeast scERV1 gene. [provided by RefSeq, Jul 2008]

MANE transcript

NM_005262.3

Inheritance

AR

ClinVar variants

P:11U:74B:60

Top phenotype

Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay

gnomAD constraint

pLI —, LoF o/e 0.87

Max pathogenic AF

—

Genomic locus

chr16:1,984,193-1,987,749

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~3.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013116

Submitter: Labcorp Genetics (formerly Invitae)

mitochondrial diseaseDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0044970

Submitter: ClinGen

The relationship between *GFER* and *GFER*-related primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of September 28, 2023. *GFER* encodes growth factor ERV1-like and functions in the Disulfide Relay System (DRS, PMID: 19409522). Alterations in this protein lead to impaired mitochondrial transport of several DRS substrates, with subsequent decreased activities of the respiratory chain including complex IV. *GFER* was first reported in relation to autosomal recessive *GFER*-related primary mitochondrial disease in 2009 (PMID: 19409522). *GFER* has been associated with a single disease entity to date, autosomal recessive myopathy, mitochondrial progressive, with congenital cataract and developmental delay [OMIM#613076]. This is one disease entity according to the ClinGen Lumping and Splitting Framework, and has been renamed as *GFER*-related primary mitochondrial disease. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included five variants (one missense, two frameshift, two termination) in four probands from three publications (PMIDs: 19409522, 26018198, 28155230). Age of onset was in the neonatal period. Clinical features in affected individuals include cataracts, ptosis, hearing loss, hypotonia, developmental delay, myopathy, epilepsy, and dysautonomia. Muscle biopsies show COX-negative fibers, ragged red fibers, abnormal mitochondrial morphology, and mitochondrial respiratory chain enzyme deficiencies. The mechanism of disease is loss of function. This gene-disease association is also supported by its known biochemical function, functional alteration in non-patient cells, rescue in patient cells, and model systems (PMIDs: 19409522). In summary, there is definitive evidence to support the relationship between *GFER* and *GFER*-related primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 28, 2023 (SOP Version *10).*

congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013116

Submitter: Orphanet

congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndromeMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0013116

Submitter: G2P

congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013116

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delayAR

Manifestation: Audiologic/Otolaryngologic; Musculoskeletal; Neurologic; Ophthalmologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 19409522Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to GFER variants in ClinVar

6 Conditions Cataloged
not providedTotal: 135
Inborn genetic diseasesTotal: 40
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndromeTotal: 19
not specifiedTotal: 9
GFER-related disorderTotal: 6
Mitochondrial diseaseTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005262.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
51
clinvar
1
clinvar
52
missense
2
clinvar
3
clinvar
70
clinvar
8
clinvar
83
nonsense
1
clinvar
2
clinvar
1
clinvar
4
start loss
0
frameshift
1
clinvar
2
clinvar
2
clinvar
5
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total4774591145

Highest pathogenic variant AF is 0.00024323515

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 7 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005262.3RefSeqNP_005253.33MANE Select
ENST00000248114.7EnsemblENSP00000248114.63MANE Select
ENST00000561710.1EnsemblENSP00000456189.12Standard
ENST00000567719.2EnsemblENSP00000455885.12Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
gferDanio rerio

Structure: exocrine pancreas

Quality: decreased size

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Metabolism of proteins
  • Mitochondrial protein import

Biological Process

  • regulation of signaling receptor activity
  • oxidation-reduction process

Molecular Function

  • protein binding
  • growth factor activity
  • protein disulfide oxidoreductase activity
  • flavin-linked sulfhydryl oxidase activity
  • flavin adenine dinucleotide binding

Cellular Component

  • extracellular region
  • mitochondrion
  • mitochondrial intermembrane space
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000248114
Coding exons
3
Length
3543
Individuals with no LoFs
125599
Homozygous LoFs
0
Heterozygous LoFs
19
Defined
125618
p
0.0000756
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.1951141081.050.000005981319
Missense (PolyPhen)4536.951.2179455
Synonymous-0.3295047.11.060.00000237410
Loss of Function0.30466.860.8752.97e-775

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish0.000890.00089rare
East Asian00.0absent
Finnish0.0000470.000046rare
European (Non-Finnish)0.0000710.000070rare
South Asian0.0000650.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Isoform 1: FAD-dependent sulfhydryl oxidase that regenerates the redox-active disulfide bonds in CHCHD4/MIA40, a chaperone essential for disulfide bond formation and protein folding in the mitochondrial intermembrane space. The reduced form of CHCHD4/MIA40 forms a transient intermolecular disulfide bridge with GFER/ERV1, resulting in regeneration of the essential disulfide bonds in CHCHD4/MIA40, while GFER/ERV1 becomes re- oxidized by donating electrons to cytochrome c or molecular oxygen. {ECO:0000269|PubMed:19397338, ECO:0000269|PubMed:20593814, ECO:0000269|PubMed:21383138, ECO:0000269|PubMed:22224850, ECO:0000269|PubMed:23186364, ECO:0000269|PubMed:23676665}.;

Recessive Scores

pRec
0.304

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.897

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.